153 related articles for article (PubMed ID: 10364835)
21. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antiprotozoal activity of cationic 2-phenylbenzofurans.
Bakunov SA; Bakunova SM; Wenzler T; Barszcz T; Werbovetz KA; Brun R; Tidwell RR
J Med Chem; 2008 Nov; 51(21):6927-44. PubMed ID: 18841956
[TBL] [Abstract][Full Text] [Related]
23. Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans.
Van Miert S; Van Dyck S; Schmidt TJ; Brun R; Vlietinck A; Lemière G; Pieters L
Bioorg Med Chem; 2005 Feb; 13(3):661-9. PubMed ID: 15653333
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Gamage SA; Figgitt DP; Wojcik SJ; Ralph RK; Ransijn A; Mauel J; Yardley V; Snowdon D; Croft SL; Denny WA
J Med Chem; 1997 Aug; 40(16):2634-42. PubMed ID: 9258370
[TBL] [Abstract][Full Text] [Related]
25. Effect of Brazilian copaiba oils on Leishmania amazonensis.
Santos AO; Ueda-Nakamura T; Dias Filho BP; Veiga Junior VF; Pinto AC; Nakamura CV
J Ethnopharmacol; 2008 Nov; 120(2):204-8. PubMed ID: 18775772
[TBL] [Abstract][Full Text] [Related]
26. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
Lang T; Goyard S; Lebastard M; Milon G
Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
[TBL] [Abstract][Full Text] [Related]
27. The effect of cicerfuran, an arylbenzofuran from Cicer bijugum, and related benzofurans and stilbenes on Leishmania aethiopica, L. tropica and L. major.
Getti GT; Aslam SN; Humber DP; Stevenson PC; Cheke RA
Planta Med; 2006 Aug; 72(10):907-11. PubMed ID: 16902862
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation.
Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM
Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894
[TBL] [Abstract][Full Text] [Related]
29. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
30. The experimental chemotherapy of leishmaniasis. II. The activity in tissue culture of some antiparasitic and antimicrobial compounds in clinical use.
Mattock NM; Peters W
Ann Trop Med Parasitol; 1975 Sep; 69(3):359-71. PubMed ID: 1155997
[TBL] [Abstract][Full Text] [Related]
31. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54.
Kayser O; Kiderlen AF; Brun R
Planta Med; 2001 Nov; 67(8):718-21. PubMed ID: 11731912
[TBL] [Abstract][Full Text] [Related]
33. Changes in the proteome and infectivity of Leishmania infantum induced by in vitro exposure to a nitric oxide donor.
Dea-Ayuela MA; Ordoñez-Gutierrez L; Bolás-Fernández F
Int J Med Microbiol; 2009 Mar; 299(3):221-32. PubMed ID: 18774335
[TBL] [Abstract][Full Text] [Related]
34. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
35. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
[TBL] [Abstract][Full Text] [Related]
36. Colorimetric assay for screening compounds against Leishmania amastigotes grown in macrophages.
Buckner FS; Wilson AJ
Am J Trop Med Hyg; 2005 May; 72(5):600-5. PubMed ID: 15891135
[TBL] [Abstract][Full Text] [Related]
37. Leishmanicidal and antiplasmodial activity of constituents of Smirnowia iranica.
Sairafianpour M; Kayser O; Christensen J; Asfa M; Witt M; Staerk D; Jaroszewski JW
J Nat Prod; 2002 Dec; 65(12):1754-8. PubMed ID: 12502308
[TBL] [Abstract][Full Text] [Related]
38. Effect of testosterone on Leishmania donovani infection levels of murine bone marrow derived-macrophages.
Yin G; Guo Z; Yin L; Zhao J; Qiao Z; Frank W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(4):251-5. PubMed ID: 12078252
[TBL] [Abstract][Full Text] [Related]
39. Effect of 3-alkylpyridine marine alkaloid analogues in Leishmania species related to American cutaneous leishmaniasis.
Machado PA; Hilário FF; Carvalho LO; Silveira ML; Alves RB; Freitas RP; Coimbra ES
Chem Biol Drug Des; 2012 Nov; 80(5):745-51. PubMed ID: 22882996
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
